Health Products Procurement and Supply Chain Management
- Page not found
- About Us
- Civil Society Groups
- electronic Vaccine Intelligence Network
- Financial Management
- Health Information Systems
- Innovation and Technologies
- Legal and Policy Support
- Non-Communicable Diseases
- Procurement and Supply Chain Management
- Programme Management
- Solar for Health
- Frequently Asked Questions
- National Coordinating Bodies
Legal and Policy
- Case Studies
- Enabling legal environments
- Identifying human rights barriers
- Key Populations
- UNDP's role
- About results
- Arab States
- Asia Pacific
- Europe & the CIS
- Impact Highlights
- Latin America & the Caribbean
- Regional Grants
Enhancing capacity. Guaranteeing quality. Improving Performance.
UNDP is taking a lead globally to support countries in the procurement of health products and to strengthen national supply chains in some of the most challenging operating environments in close collaboration with other partners. The expertise built through 15 years of supporting the PSM implementation of donor grants in such contexts is being used to support ongoing reforms in national procurement system and to strengthen national supply chain systems.
The objective is to help countries to deliver value-for-money, to guarantee the quality of the products and services provided - and to improve the performance of national procurement and supply chain systems using domestic funds.
UNDP health procurement volumes
Total Health Procurement Volume 2017
$310 Million USD
In collaboration with UNICEF, UNFPA, GDF/UNOPS
Key Categories of Medicines
PSM capacity development
Health procurement has been used as an entry point to build resilience in Procurement and Supply Chain Management (PSM) in countries. While supporting the timely procurement of quality-assured medicines and other health products, UNDP works with governments, in coordination with WHO and other partners, to help enhance national capacities and systems for adequate management of and technical aspects of PSM, through transparent and accountable mechanisms. Another point of entry for PSM strengthening is supporting the development, review and implementation of PSM strategies and plans.
UNDP’s strategic support includes providing technical expertise to strengthen policy and regulatory frameworks, manage intellectual property rights, improving procurement strategies and regulations, and removing potential barriers to equitable access to affordable medicines. The UNDP approach to capacity development contributes to a resilient and sustainable PSM cycle by:
- defining appropriate quality requirements for selected products;
- quantifying needs;
- sourcing, planning and conducting procurement processes;
- storing and distributing medicines and other health products while controlling their quality;
- establishing information systems for the monitoring of stocks, and consumption;
- designing solutions for ‘last-mile’ delivery to the most hard-to-reach populations.
UNDP’s approach to PSM Strengthening
The approach ensures that capacity gaps are identified and analysed and UNDP can assist countries to assess national supply chains, as well as the development of national PSM strategies and implementation plans. The development of these documents is essential to ensure; i) the contributions of partners will support the development of resilient and sustainable national supply chain systems; ii) to increase the alignment of partners to national priorities; and iii) to reduce the creation of parallel supply systems.
UNDP is also encouraging the establishment of national coordination platforms under the leadership of the Ministries of Health to ensure regular monitoring of the implementation of PSM strategies and plans and to monitor the performance of the system. All national and international actors involved in PSM activities in the country should be part of this coordination mechanism.
Based on these strategies and plans, UNDP in consultation with other partners and donors will support the implementation of specific activities in close collaboration with national counterparts to strengthen national leadership and management. Activities will be identified to strengthen the PSM cycle, as well as addressing the main enablers of a functional national PSM system.
Support will be also provided to measure progress, overcome challenges and to monitor the performance of the national systems through key performance indicators.
Human Capacity for PSM
In several countries, UNDP has strengthened human resources through a scaling-up of on-the-job and formal trainings and provided access to professional qualifications for health workers in PSM related areas including obtaining accreditation from the internationally recognized Chartered Institute of Purchasing and Supply (CIPS).
UNDP has also developed online introductory training courses accessible in four UN languages on procurement and supply chain management aimed at supporting capacity development in countries and increasing the understanding of the importance of PSM to ensure the uninterrupted supply of life-saving medicines and other health products.
To develop resilient and sustainable systems for health UNDP can mobilize international technical assistance (TA) through the UNDP Health PSM expert roster.
Innovations in PSM
- Upstream innovation for sustainable procurement such as engaging manufacturers through its Long-Term Agreements to optimize medicines packaging to reduce waste.
- Innovation implemented in the supply chain includes mobile phone-based Logistic Management Information Systems (LMIS), which allows tracking of inventory, consumption data and monitor cold chain temperature for vaccines at the most peripheral level
- The Solar for Health initiative ensures sustainable provision of electricity to pharmaceutical warehouses and health facilities guaranteeing not only the functioning of cold chain equipment but also storage of health products at controlled temperature and electricity for computer-based Warehouse Management System (WMS) and LMIS.
- UNDP, jointly with other agencies of the Interagency Supply Chain Group (ISG), is promoting the adoption of the Global Data Standards (GS1) to improve traceability of medicines along national supply chains. This could also improve the security in national supply chains and reduce the risk of falsification and illicit distribution of medical products.
All these innovations are aimed to build national resilient and sustainable supply chain systems.
UNDP is also participating with other agencies to coordinating mechanisms such as the Interagency Supply Chain Group (ISG) and the Sustainable procurement in the Health Sector (SPHS) to coordinate the introduction of innovations and use of technologies in procurement and supply chain management.
Value for Money
UNDP has developed and continues to manage a procurement architecture designed to facilitate the timely supply of affordable quality assured pharmaceutical and other health products to meet the needs of national programs using donor grants and domestic funds for health procurement supported by UNDP through a value for money service proposition. The UNDP health procurement architecture comprises several partnerships and sourcing agreements with other UN Agencies, manufacturers and other commercial entities to provide the most cost-efficient procurement system for each health product category.
As a result, UNDP health procurement has achieved very competitive prices for health products. For example, in 2016 efficiencies of $29.6 million USD in the procurement of antiretrovirals (ARVs) were generated as compared to the previous year. These savings are reinvested to support increased health service coverage or to strengthen national supply chain systems. Similarly, UNDP’s capacity building for in-country procurement processes and operations aims to achieve efficiencies to be re-invested to strengthen other areas of the PSM cycle.
UNDP is also working to reduce monetary and environmental costs related to transportation and waste of medicines’ packaging assuring additional value for money in health procurement for recipient countries. In the future, this type of approach is meant to be transferred and applied in country-led procurement processes supported by UNDP.
This has included; i) carrying out a comprehensive assessment of the Pharmaceutical Supply Chain System in 2013 and using the findings to develop a costed action plan; ii) working with the Ministry of Health and Child Care (MoHCC), the Country Coordination Mechanism (CCM) and key partners to mobilize funding to implement the costed action plan; iii) working with the Ministry of Health and Child Care (MOHCC) and partners in developing strong quantification processes for health products; iv) strengthening quality assurance of health products by the Medicines Control Authority of Zimbabwe (MCAZ); iii) working with the National Pharmaceutical Company (NatPharm) - the central medical store - to develop their capacity since 2011; and v) carrying out a comprehensive assessment of the laboratory supply chain system in 2016 and developing a costed action plan for implementation during 2018-2020; and vi) developing a Viral Load reagent rental agreement for HIV Viral Load testing. This has all led to increased access to essential medicines and other health products beyond malaria, HIV and tuberculosis.
Strengthen global and in-country procurement and supply chain systems
Improved access to essential medicines and health products is critical to reaching universal health coverage and is recognized as a key building block of a strong system for health. Weak procurement and ineffective supply chains weaken the overall health system’s ability to respond to the healthcare needs of the population. As part of its new strategy ‘The Global Fund Strategy 2017-2022: Investing to End Epidemics’ the Global Fund is prioritizing investments in building Resilient and Sustainable Systems for Health (RSSH).
The Global Fund is identifying specific funding opportunities for countries to focus on developing capacity in systems that not only affect the three diseases but the full national health programme as well. PSM Capacity Development should focus on;
- Effective operationalization of procurement and supply chain systems: Developing the capacity of supply chain systems to ensure appropriate and uninterrupted supply of medicines, health products and technologies all along the supply chain. Countries are encouraged to design cross-cutting interventions to ensure that the national procurement and supply chain system is strengthened, not just disease-specific supply chains.
- Improvement and development of procurement and supply chain systems infrastructure and tools: Strengthening the storage and distribution of medicines and other health products, such as reliable warehousing, distribution and logistics management information systems (LMIS), and investing in innovative information technologies and capacity to manage national forecasting and supply planning.